TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Click for best price
This report contains market size and forecasts of COPD Drug Delivery Devices in global, including the following market information:
Global COPD Drug Delivery Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global COPD Drug Delivery Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five COPD Drug Delivery Devices companies in 2021 (%)
The global COPD Drug Delivery Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
MDI Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of COPD Drug Delivery Devices include AstraZeneca, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Novartis AG, Teva Pharmaceutical Industries, Merck & Co., Inc., Sunovion Pharmaceuticals, Inc., Koninklijke Philips and Omron Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the COPD Drug Delivery Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global COPD Drug Delivery Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global COPD Drug Delivery Devices Market Segment Percentages, by Type, 2021 (%)
MDI
DPI
Global COPD Drug Delivery Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global COPD Drug Delivery Devices Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global COPD Drug Delivery Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global COPD Drug Delivery Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies COPD Drug Delivery Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies COPD Drug Delivery Devices revenues share in global market, 2021 (%)
Key companies COPD Drug Delivery Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies COPD Drug Delivery Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Boehringer Ingelheim GmbH
GlaxoSmithKline plc
Novartis AG
Teva Pharmaceutical Industries
Merck & Co., Inc.
Sunovion Pharmaceuticals, Inc.
Koninklijke Philips
Omron Corporation
Cipla Inc.
PARI GmbH
| Report Attributes | Report Details |
|---|---|
| Report Title | COPD Drug Delivery Devices Market, Global Outlook and Forecast 2022-2028 |
| Historical Year | 2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year | 2021 |
| Forecast Year | 2029 |
| Number of Pages | 79 Pages |
| Customization Available | Yes, the report can be customized as per your need. |
Frequently Asked Questions ?
